Randomised Controlled TrialtaVNSn = 52

The efficacy and safety of transcutaneous auricular vagus nerve stimulation in patients with mild cognitive impairment: A double blinded randomized clinical trial

Wang L, Zhang J, Guo C, He J, Zhang S, Wang Y, Zhao Y, Li L, Wang J, Hou L, et al.

Brain Stimulation · 2022

Key finding

After 24 weeks, taVNS significantly improved MoCA scores, verbal learning, naming ability, and sleep quality in patients with mild cognitive impairment, suggesting potential to delay cognitive decline.

Auto-extracted · verification pendingHow we verify

Condition
Cognitive Function
Stimulation
taVNS
Evidence tier
Randomised Controlled Trial
Participants
52
View on PubMed

Share this study

Download the citation card as a PNG, or copy a link to this page.

Cite this study

Wang, L., Zhang, J., Guo, C., He, J., Zhang, S., Wang, Y., Zhao, Y., Li, L., Wang, J., Hou, L., Li, S., Wang, Y., Hao, L., Zhao, Y., Wu, M., Fang, J., & Rong, P. (2022). The efficacy and safety of transcutaneous auricular vagus nerve stimulation in patients with mild cognitive impairment: A double blinded randomized clinical trial. Brain Stimulation.

Related studies in Cognitive Function

Summary by Vagus Research. Always consult the primary source for the authoritative record.

Stay Current with the Research

Join researchers and practitioners exploring the science of vagus nerve stimulation. Receive curated research summaries and evidence updates.

No spam. Unsubscribe at any time. We respect your privacy.